INT210591

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.47
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.46
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (Tnfsf11) extracellular space (Tnfsf11) extracellular region (Tnfsf11)
plasma membrane (Tnfsf11) intracellular (Tnfsf11) cytoplasm (Tnfsf11)
Tnfsf11 (Mus musculus)
Pain Link Frequency Relevance Heat
tolerance 1 53.52 Quite High
corticosteroid 2 36.36 Quite Low
cytokine 8 5.00 Very Low Very Low Very Low
chemokine 6 5.00 Very Low Very Low Very Low
antagonist 5 5.00 Very Low Very Low Very Low
Inflammation 4 5.00 Very Low Very Low Very Low
Spinal cord 1 5.00 Very Low Very Low Very Low
depression 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Malignant Neoplastic Disease 5 99.72 Very High Very High Very High
Hypercalcemia 59 99.44 Very High Very High Very High
Cancer 29 88.36 High High
Multiple Myeloma 9 80.96 Quite High
Breast Cancer 2 79.36 Quite High
Metastasis 2 76.88 Quite High
Bone Cancer 19 67.72 Quite High
Toxicity 1 54.00 Quite High
Reprotox - General 1 1 45.60 Quite Low
Solid Tumor 3 43.44 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Interestingly, data from preclinical studies in murine models of humoral hypercalcemia of malignancy suggest that inhibition of RANKL, using OPG-Fc, causes greater suppression of bone resorption and hypercalcemia than do bisphosphonates [41].
Positive_regulation (causes) of Negative_regulation (inhibition) of RANKL associated with malignant neoplastic disease and hypercalcemia
1) Confidence 0.47 Published 2007 Journal Arthritis Res Ther Section Body Doc Link PMC1924519 Disease Relevance 1.46 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox